Articles published by United Therapeutics Corporation
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240627817218/en/2168250/5/2021_Preferred_MalcolmGOVnew.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
UTHR
![](https://mms.businesswire.com/media/20240424110823/en/2111202/22/PR_Image_01-01.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
March 25, 2024
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
February 21, 2024
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 29, 2023
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
December 07, 2023
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
September 22, 2023
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
September 12, 2023
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 01, 2023
Via Business Wire
Tickers
UTHR
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
UTHR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.